Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Fung · SciRah

Researcher profile · Semantic Scholar

H. Fung

Share profile

H. Fung — researcher profile on SciRah

h-index: 28
Works: 161
Citations: 5,171

Most-cited papers

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael L. Wang, J. Muñoz, A. Goy, F. Locke +21 more
2020New England Journal of Medicine1,449 citations Open access
Semantic Scholar
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
C. Jacobson, J. Chavez, A. Sehgal, B. William +19 more
2021The Lancet Oncology523 citations
Semantic Scholar
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.
Lori S. Muffly, M. Pasquini, Michael J. Martens, R. Brazauskas +47 more
2017Blood267 citations Open access
Semantic Scholar
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
Shaji K. Kumar, N. Callander, M. Alsina, D. Atanackovic +25 more
2017The Journal of the National Comprehensive Cancer Network266 citations Open access
Semantic Scholar
Phase II Study of the PD1-inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma
Stefan K. Barta, J. Zain, A. MacFarlane, Sonali M. Smith +13 more
2019Clinical Lymphoma, Myeloma & Leukemia113 citations Open access
Semantic Scholar
Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
C. Jacobson, J. Chavez, A. Sehgal, B. William +21 more
2020110 citations Open access
Semantic Scholar
Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
Manish Sharma, Mei-Jie Zhang, X. Zhong, M. Abidi +32 more
2014Biology of Blood and Marrow Transplantation81 citations Open access
Semantic Scholar
NCCN Guidelines® Insights Multiple Myeloma, Version 3.2016
Kenneth C. Anderson, M. Alsina, D. Atanackovic, J. S. Biermann +25 more
2016The Journal of the National Comprehensive Cancer Network72 citations Open access
Semantic Scholar
Multiple Myeloma, Version 2.2016
Kenneth C. Anderson, M. Alsina, D. Atanackovic, J. S. Biermann +25 more
2015The Journal of the National Comprehensive Cancer Network67 citations Open access
Semantic Scholar
The Notch ligand DLL4 defines a capability of human dendritic cells in regulating Th1 and Th17 differentiation
Lijun Meng, Zhen-Jiang Bai, Shan He, Kazuhiro Mochizuki +15 more
2015Journal of Immunology61 citations Open access
Semantic Scholar
Long-Term Outcomes Among Two-Year Survivors of Autologous Hematopoietic Cell Transplant for Hodgkin and Diffuse Large B-Cell Lymphoma
Regina M. Myers, B. Hill, B. Shaw, Soyoung Kim +30 more
2017Cancer53 citations Open access
Semantic Scholar
THE IMPACT OF GRAFT VERSUS HOST DISEASE ON RELAPSE RATE IN PATIENTS WITH LYMPHOMA DEPENDS ON THE HISTOLOGICAL SUB-TYPE AND THE INTENSITY OF THE CONDITIONING REGIMEN
Á. Urbano-Ispizua, S. Pavletic, M. Flowers, J. Klein +33 more
2015Biology of Blood and Marrow Transplantation53 citations Open access
Semantic Scholar
Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL).
C. Jacobson, J. Chavez, A. Sehgal, B. William +16 more
202049 citations
Semantic Scholar
Post-transplant outcomes in high-risk compared to non-high risk multiple myeloma, a CIBMTR analysis
E. Scott, P. Hari, Manish Sharma, J. Le-Rademacher +29 more
2016Biology of Blood and Marrow Transplantation41 citations Open access
Semantic Scholar
Gastrointestinal Side Effects and Adequacy of Enteral Intake in Hematopoietic Stem Cell Transplant Patients
M. Walrath, Cheryl A. Bacon, S. Foley, H. Fung
2014Nutrition in clinical practice40 citations Open access
Semantic Scholar
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.
Qingrong Huang, Shan He, Yuanyuan Tian, Yuting Gu +15 more
2017Blood34 citations Open access
Semantic Scholar
A simplified technique for delivering total body irradiation (TBI) with improved dose homogeneity.
R. Yao, D. Bernard, J. Turian, Rosss A. Abrams +3 more
2012Medical Physics (Lancaster)34 citations
Semantic Scholar
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation
G. Peksa, K. Schultz, H. Fung
2014Journal of Oncology Pharmacy Practice28 citations Open access
Semantic Scholar
Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
Kazuhiro Mochizuki, Lijun Meng, I. Mochizuki, Qing Tong +11 more
2016Blood25 citations Open access
Semantic Scholar
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Woonbok Chung, Andrew D Kelly, Patricia Kropf, H. Fung +6 more
2019Clinical Epigenetics24 citations Open access
Semantic Scholar
Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis
L. Paganessi, A. Walker, L. Tan, Isaac Holmes +3 more
2010Experimental Hematology24 citations Open access
Semantic Scholar
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Reem Karmali, M. Kassar, P. Venugopal, J. Shammo +4 more
2011Clinical Lymphoma, Myeloma & Leukemia19 citations
Semantic Scholar
Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors
C. Abboud, Nicole Lang, H. Fung, A. Lammerich +7 more
2018Supportive Care in Cancer17 citations
Semantic Scholar
Increasing Use of Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients Age 70 Years and Older: A CIBMTR Study of Trends and Outcomes
Lori S. Muffly, M. Pasquini, Michael J. Martens, R. Brazauskas +36 more
201617 citations Open access
Semantic Scholar
One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Michael L. Wang, J. Muñoz, A. Goy, F. Locke +21 more
202016 citations Open access
Semantic Scholar
Anger, provider responses, and pain: prospective analysis of stem cell transplant patients.
James I. Gerhart, Veronica Sanchez Varela, J. Burns, S. Hobfoll +1 more
2015Health Psychology14 citations
Semantic Scholar
A phase 1 dose‐escalation study of XmAb®2513 in patients with relapsed or refractory Hodgkin lymphoma
Anita Kumar, K. Blum, H. Fung, Mitchell R. Smith +2 more
2015British Journal of Haematology13 citations Open access
Semantic Scholar
Posttraumatic stress symptoms predict impaired neutrophil recovery in stem cell transplant recipients
S. Hobfoll, James I. Gerhart, A. Zalta, Kurrie Wells +2 more
2015Psycho-Oncology12 citations Open access
Semantic Scholar
CD26 Protease Inhibition Improves Functional Response of Un-fractionated Cord Blood, Bone Marrow, and Mobilized Peripheral Blood Cells to CXCL12/SDF-1
K. Christopherson, Robin R. Frank, Sucheta Jagan, L. Paganessi +2 more
2012Experimental Hematology11 citations Open access
Semantic Scholar
Sequential single-agent obatoclax mesylate (GX15–070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma
A. Goy, M. Berger, Peggy K. Ford, T. Feldman +3 more
2014Leukemia and Lymphoma10 citations
Semantic Scholar
Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost,
Nelson J. Chao, D. Grima, G. Carrum, L. Holmberg +9 more
20119 citations
Semantic Scholar
A Phase I Trial Assessing the Feasibility of Romidepsin Combined with Brentuximab Vedotin for Patients Requiring Systemic Therapy for Cutaneous T-Cell Lymphoma
S. Barta, T. Feldman, J. Desimone, Ellen J. Kim +6 more
2020Blood8 citations Open access
Semantic Scholar
Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?
N. Hossain, T. Klumpp, J. Ulicny, M. Garner +5 more
2016Clinical Lymphoma, Myeloma & Leukemia8 citations
Semantic Scholar
Loss of CD26 Protease Activity in Recipient Mice during Hematopoietic Stem Cell Transplantation Results in Improved Transplant Efficiency
E. Yoo, L. Paganessi, Wasfia A. Alikhan, Elizabeth A. Paganessi +5 more
2012Transfusion8 citations Open access
Semantic Scholar
In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice.
Shannon M. Kidd, C. Bueso-Ramos, Sucheta Jagan, L. Paganessi +4 more
2011Experimental Hematology7 citations Open access
Semantic Scholar
Brentuximab Vedotin with R-CHP Chemotherapy As Frontline Treatment for Patients with CD30 Positive Primary Mediastinal Large B-Cell, Diffuse Large B-Cell, and Grey Zone Lymphomas: Results of a Phase I/II Multisite Trial
J. Svoboda, D. Landsburg, S. Nasta, S. Barta +15 more
20175 citations
Semantic Scholar
IBCL-124: Interim Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL)
C. Jacobson, J. Chavez, A. Sehgal, B. William +16 more
20204 citations
Semantic Scholar
Neutropenia Recovery Linked to Filgrastim Initiation Timing After Autologous Hematopoietic Stem-Cell Transplantation
H. Fung, Frcpe
20164 citations
Semantic Scholar
Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics
A. Jimenez, H. Fung, K. Christopherson
2011Transfusion4 citations
Semantic Scholar
CD38 Expression Loss in Multiple Myeloma Treated with Daratumumab
N. Hotchandani, H. Fung, E. Dulaimi
20163 citations Open access
Semantic Scholar
Pembrolizumab and Copanlisib for the Treatment of Relapsed or Refractory Mature T-Cell Lymphomas
S. Barta, N. Fowler, J. Zain, J. Ruan +12 more
2019Blood2 citations
Semantic Scholar
The impact of posttraumatic stress symptoms on social support and social conflict during hematopoietic stem cell transplant
James I. Gerhart, Yasmin Asvat, Teresa A. Lillis, H. Fung +2 more
2018Journal of psychosocial oncology2 citations
Semantic Scholar
CMV and BK Virus Reactivation in Post Transplant Cyclophosphamide (PTCY) after Allogeneic MUD, MRD and Haploidentical Transplant
T. Wang, M. Sochat, C. Tan, N. Hossain +5 more
20172 citations Open access
Semantic Scholar
Blast Percentage Prior to Transplantation Is the Strongest Predictive Factor for Survival After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Patients with Myelodysplastic Syndrome (MDS)
A. Jimenez, E. Rich, S. Nathan, J. Maciejewski +5 more
20122 citations Open access
Semantic Scholar
High-dose chemotherapy with autologous stem cell rescue for relapse after allo-SCT in multiple myeloma
H. Tuncer, S. Gregory, H. Fung
2011Bone Marrow Transplantation2 citations Open access
Semantic Scholar
Update on a Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front Line Therapy for Patients with Indolent Lymphomas
Reem Karmali, M. Kassar, A. Jimenez, P. Venugopal +5 more
20102 citations
Semantic Scholar
One-Year Follow-up of ZUMA-2, the Multicenter, Registrational Study of KTE-X19 in Patients (Pts) with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)
Michael L. Wang, J. Muñoz, A. Goy, F. Locke +21 more
20211 citations Open access
Semantic Scholar
Primary Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
C. Jacobson, J. Chavez, A. Sehgal, B. William +21 more
20211 citations Open access
Semantic Scholar
Engineering of Chimeric Antigen Receptor T Cells with integrin αEβ7 Results in Augmented Therapeutic Efficacy against E-cadherin positive tumor
Hongxing Sun, Shan He, Lijun Meng, Ying Wang +10 more
2019bioRxiv1 citations Open access
Semantic Scholar
Engineering of CD19-Specific Chimeric Antigen Receptor T Cells with the Integrin CD103 Results in Augmented Therapeutic Efficacy Against Human Lymphoma in a Preclinical Model
Hongxing Sun, Shan He, Lijun Meng, Ying Wang +10 more
2018Blood1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Reshef×9
Invite
R. Reshef — researcher profile on SciRah
J. Muñoz×8
Invite
J. Muñoz — researcher profile on SciRah
C. Jacobson×8
Invite
C. Jacobson — researcher profile on SciRah
A. Beitinjaneh×7
Invite
A. Beitinjaneh — researcher profile on SciRah

×6

Invite

J. Rossi — researcher profile on SciRah

Invite

D. Maloney — researcher profile on SciRah

Invite

H. Lazarus — researcher profile on SciRah

Invite

L. Holmberg — researcher profile on SciRah

Invite

J. Chavez — researcher profile on SciRah

Invite

A. Sehgal — researcher profile on SciRah

Invite

B. William — researcher profile on SciRah

Invite

G. Salles — researcher profile on SciRah